STRONG STAR consortium advances PTSD treatment for soldiers
The STRONG STAR consortium, based at the University of Texas Health Science Center in San Antonio, is at the forefront…
The STRONG STAR consortium, based at the University of Texas Health Science Center in San Antonio, is at the forefront…
Recent research highlights a significant placebo response in patients with Attention Deficit Hyperactivity Disorder (ADHD), raising concerns for the development…
MindMed (MNMD) is leading innovative research into psychedelic-assisted therapies and is now progressing to Phase 3 clinical trials for its…
A Mississippi lawmaker plans to introduce a bill aimed at initiating clinical trials for ibogaine, a psychedelic drug that some…
Silo Pharma, Inc. (NASDAQ:SILO), based in Sarasota, Florida, is advancing its research on a new intranasal therapy aimed at treating…
Silo Pharma, a biopharmaceutical company focused on developing treatments for mental health disorders, has taken a significant step forward in…
Компания Helix Clinical Research объявила о партнерстве с Southern Illinois Associates с целью расширения клинических исследований в области психического здоровья в метрополитене...
Американская фармацевтическая компания MindMed начала третью фазу клинических испытаний своего препарата MM120 (лизергид д-тартрат) на основе ЛСД, направленного на борьбу с генерализованной...